做多

CWBR CohBar retracement completed ! Buy opportunity?

CWBR CohBar is developing mitochondria based therapeutics for the treatment of age-related diseases.
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.

WBB Securities upgraded CohBar, Inc. stock to Buy from Speculative Buy with a price target of $5.

On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00

The Market Cap is only 72.138M

I see a lot of potential in this stock! Do you?

TopgOptions

DAILY PRIVATE HIGH-CONVICTION OPTIONS SIGNALS: patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/

此外:

免責聲明

這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。

TopgOptions

此外: